Osteonecrosis of the femoral head (ONFH) is a common and refractory disease.1 Increasing evidence suggests inflammatory osteoimmunology plays an indispensable role in the pathogenesis of ONFH.
M1 macrophages produce pro-inflammatory cytokines, whereas M2 macrophages produce anti-inflammatory cytokines.2 A disbalance in favour of the M1 phenotype can result in chronic inflammation, which then contributes to ONFH. The shift from M1 to M2 phenotype effectively decreases inflammatory cytokines and alleviates the symptoms of ONFH.3
The cytokines of interleukin (IL)-23/IL-33 produced by T cells may predict risk for ONFH.4 The elevated levels of T helper cell (Th)17 and IL-17 in both synovium and peripheral blood in ONFH patients indicated a correlation between inflammation and ONFH.5 Th9/Th17 cells secrete IL-9 to upregulate inflammatory cytokines that degrade cartilage matrix.6 Regulator T (Treg) cells secrete anti-inflammatory cytokines to inhibit osteoclast activity, thereby preventing bone damage. Inhibitory T cells can also suppress osteoclast activity by binding to osteoclast precursors, and the reduction in its number may be associated with ONFH progression.7 B cells induce humoral responses and inflammation that contributes to ONFH.8
Activated neutrophils release so-called “neutrophil extracellular traps” (NETs). The NET-forming neutrophils appear to disturb local blood flow, and stimulate thrombus formation and coagulation in the small vessels surrounding the femoral head, contributing to ONFH.9
Signalling moleculars associated with osteoimmunology of ONFH may include several pathways such as Janus kinase (JAK)-signal transducer and activator of transcription (STAT), c-Jun N-terminal kinase (JNK), and Toll-like receptor (TLR)4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).2,6,10 Future research should clarify the inflammatory signalling mechanisms, as well as interactions between immune cells and other cell types that contribute to ONFH. Relevant clinical studies shoud also be conducted to fill the gap from theory to practice.
Fig. 1
References
1. Sodhi N , Acuna A , Etcheson J , et al. Management of osteonecrosis of the femoral head . Bone Joint J . 2020 ; 102-B ( 7_Supple_B ): 122 – 128 . Crossref PubMed Google Scholar
2. Das A , Sinha M , Datta S , et al. Monocyte and macrophage plasticity in tissue repair and regeneration . Am J Pathol . 2015 ; 185 ( 10 ): 2596 – 2606 . Crossref PubMed Google Scholar
3. Jiang C , Zhou Z , Lin Y , et al. Astragaloside IV ameliorates steroid-induced osteonecrosis of the femoral head by repolarizing the phenotype of pro-inflammatory macrophages . Int Immunopharmacol . 2021 ; 93 : 107345 . Crossref PubMed Google Scholar
4. Wang T , Azeddine B , Mah W , Harvey EJ , Rosenblatt D , Séguin C . Osteonecrosis of the femoral head: genetic basis . Int Orthop . 2019 ; 43 ( 3 ): 519 – 530 . Crossref PubMed Google Scholar
5. Zou D , Zhang K , Yang Y , et al. Th17 and IL-17 exhibit higher levels in osteonecrosis of the femoral head and have a positive correlation with severity of pain . Endokrynol Pol . 2018 ; 69 ( 3 ): 283 – 290 . Crossref PubMed Google Scholar
6. Geng W , Zhang W , Ma J . IL-9 exhibits elevated expression in osteonecrosis of femoral head patients and promotes cartilage degradation through activation of JAK-STAT signaling in vitro . Int Immunopharmacol . 2018 ; 60 : 228 – 234 . Crossref PubMed Google Scholar
7. Ma J , Ge J , Gao F , et al. The role of immune regulatory cells in nontraumatic osteonecrosis of the femoral head: a retrospective clinical study . Biomed Res Int . 2019 ; 2019 : 1302015 . Crossref PubMed Google Scholar
8. Zhang H , Xiao F , Liu Y , Zhao D , Shan Y , Jiang Y . A higher frequency of peripheral blood activated B cells in patients with non-traumatic osteonecrosis of the femoral head . Int Immunopharmacol . 2014 ; 20 ( 1 ): 95 – 100 . Crossref PubMed Google Scholar
9. Nonokawa M , Shimizu T , Yoshinari M , et al. Association of neutrophil extracellular traps with the development of idiopathic osteonecrosis of the femoral head . Am J Pathol . 2020 ; 190 ( 11 ): 2282 – 2289 . Crossref PubMed Google Scholar
10. Zhu D , Yu H , Liu P , et al. Calycosin modulates inflammation via suppressing TLR4/NF-κB pathway and promotes bone formation to ameliorate glucocorticoid-induced osteonecrosis of the femoral head in rat . Phytother Res . 2021; Epub ahead of print . Crossref PubMed Google Scholar
Author contributions
M. Ma: Conceptualization, Writing – original draft.
Z. Tan: Writing – review & editing, Funding acquisition.
W. Li: Writing – review & editing.
H. Zhang: Writing – review & editing.
Y. Liu: Conceptualization, Writing – review & editing, Funding acquisition.
C. Yue: Conceptualization, Writing – review & editing, Funding acquisition.
Funding statement
The authors disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: the National Natural Science Foundation of China (82074472, 81804126 and 82102574); Project of science and technology of the Henan province (202102310179); and China Postdoctoral Science Foundation (2020M682298).
Acknowledgements
We would like to thank A. Chapin Rodríguez PhD for English language editing, and we also give our sincere thanks to Doctor Junming Chen and Peilin He for literature retrieval.
